Experienced AI and Healthcare Technology Lawyer Keo McKenzie Rejoins Baker McKenzie as a Partner in Washington, DC

Leading global law firm Baker McKenzie announced today that Keo (Shaw) McKenzie has rejoined the Firm's North America Intellectual Property & Technology Practice Group as a Partner in Washington, DC. Keo, who previously was an associate at the Firm and in-house digital health counsel, further strengthens Baker McKenzie's AI, Technology, Healthcare & Life Sciences, and FDA capabilities.

With over a decade of experience, Keo advises clients on a range of regulatory and transactional issues, focusing on those involving AI and digital health technologies. As former senior health products counsel for a multinational technology company, Keo has extensive experience advising on regulatory and commercial issues related to novel software-based health technologies. She has helped clients across various sectors stand up global AI governance frameworks and handled complex technology transactions related to digital health and digital transformations. Additionally, Keo will be an important part of the Firm's cross-practice AI team and provide support for the Firm's multi-jurisdictional product counseling practice.

"IP and data are significant value drivers for new products and services and transactions as enterprises look to new technologies, such as AI, and new opportunities, such as data monetization," said Brian Hengesbaugh, chair of the North America Intellectual Property & Technology Practice Group. "Keo's depth of experience in healthcare, life sciences, AI and other emerging technology matters will be invaluable as we continue to address the evolving legal needs of our clients in the AI and digital health spaces. We are thrilled to welcome her back to the team."

Baker McKenzie's robust IP and technology transactional teams advise clients on the latest technological and market developments, rapidly evolving global legal and regulatory environment for AI, as well as provide unique insights in identifying, protecting and preserving the value of IP rights in transactions. The team connects across the globe to provide deep sector and local knowledge, commercial pragmatism and the ability to craft business-minded solutions. The Firm's technology, AI, healthcare and life sciences practitioners focus on navigating complex regulatory environments, data privacy, cybersecurity, intellectual property and new and emerging technologies.

"Keo will be a great complement to our impressive bench of regulatory practitioners in Washington," said Maurice Bellan, Managing Partner of Baker McKenzie's Washington, DC, office. "Keo has already proven herself as a highly valued, collaborative team player and consistent high performer, and she has become a thought leader at the intersection of AI and digital health. We are confident she will be a great mentor to the next generation of associates and will provide invaluable leadership at the Firm."

"I am eager to rejoin Baker McKenzie and further develop its technology and life science practices," added Keo. "The Firm's forward-thinking approach and collaborative culture provide an ideal environment to tackle the evolving legal challenges in AI, digital health and other technologies, and my experience working on these issues in multiple jurisdictions makes for a great match. Baker McKenzie has a commitment to innovation as well as a truly international outlook, and I look forward to working alongside such a talented and diverse team."

Co-chair of the California Lawyers Association AI Steering Group, Keo received her M.A. in Neuroscience from Cambridge University, her LL.B. from Nottingham Law School, and her P.G.D. in Intellectual Property Law from the University of Oxford. She is licensed to practice law in California and England and Wales.